 |
|
Study points to possibility of blood test to detect lung cancer
December 10, 2007DURHAM, N.C. -- A test for four blood proteins may provide a less-invasive follow-up for patients who have suspicious lesions on chest radiographs or computerized tomography (CT) scans, according to a new study led by Duke University Medical Center researchers.
"CT scans have a very high false positive rate when trying to discover lung cancer," said Edward Patz, Jr., M.D., a radiologist at Duke and lead investigator on the study. "What that leads to is several follow-up imaging studies or invasive procedures like biopsy, which have risks of their own. This study is the first step in developing a test that would allow us to sample a patient's blood and determine whether more invasive testing and treatment are necessary."
The researchers published their findings in the December 10, 2007 issue of the Journal of Clinical Oncology. The study was funded by Duke's Department of Radiology.
Researchers studied four proteins in the blood and found that their levels were different in patients with lung cancer as compared to patients of the same age and gender who didn't have cancer. They compared the levels of these proteins in the blood of almost 100 patients known to have lung cancer to the levels in the blood of nearly 100 patients without cancer.
"Using the four markers, known as CEA, RBP, SCC and AAT, we were able to distinguish patients who had cancer from those who didn't with over 80 percent accuracy," Patz said.
The four protein markers have all been associated with lung cancer, but none in isolation wields enough influence to definitively indicate the disease. However, in combination they may be very useful, Patz said.
The researchers created a "classification tree" to sort out a person's likelihood of having lung cancer, based on the levels of each of the four proteins. "People whose samples landed in one of three bins at the bottom of the tree had a 90 percent chance of having cancer," Patz said. "Other bins indicated risks as low as 10 percent."
CT scanning has been proposed for routine lung cancer screening, but it detects many nodules that are not cancerous, leading to more invasive and risky treatment. A recent study found that nodules were detected in more than 70 percent of those screened, while lung cancer was found in less than three percent.
"We talk about how devastating this disease is all the time, but we still don't have a screening system in place that can detect lung cancer early, without exposing patients to the risks of biopsy and surgery," Patz said. "This study is an important step in the right direction."
The researchers will next perform a larger study looking at the use of biomarkers prospectively in patients found to have lung lesions by CT scan. The ultimate goal is to develop a screening system by which patients could have the blood test before imaging and those found to be in a "high risk bin" would have a CT scan for further evaluation.
"We would determine whether the person is at low or high risk of having lung cancer based on these biomarkers," Patz said. "Patients at low risk might be followed with further blood tests or imaging studies while those at high risk might require immediate intervention."
Lung cancer is the leading killer of men and women in the United States, with nearly 175,000 people diagnosed each year, and about 160,000 patients dying from the disease yearly. More than 75 percent of lung cancer patients have already experienced significant disease spread by the time they are diagnosed, making the need for early detection techniques imperative.
Duke University Medical Center
Researchers studied four proteins in the blood and found that their levels were different in patients with lung cancer as compared to patients of the same age and gender who didn't have cancer. They compared the levels of these proteins in the blood of almost 100 patients known to have lung cancer to the levels in the blood of nearly 100 patients without cancer.
"Using the four markers, known as CEA, RBP, SCC and AAT, we were able to distinguish patients who had cancer from those who didn't with over 80 percent accuracy," Patz said.
The four protein markers have all been associated with lung cancer, but none in isolation wields enough influence to definitively indicate the disease. However, in combination they may be very useful, Patz said.
The researchers created a "classification tree" to sort out a person's likelihood of having lung cancer, based on the levels of each of the four proteins. "People whose samples landed in one of three bins at the bottom of the tree had a 90 percent chance of having cancer," Patz said. "Other bins indicated risks as low as 10 percent."
CT scanning has been proposed for routine lung cancer screening, but it detects many nodules that are not cancerous, leading to more invasive and risky treatment. A recent study found that nodules were detected in more than 70 percent of those screened, while lung cancer was found in less than three percent.
"We talk about how devastating this disease is all the time, but we still don't have a screening system in place that can detect lung cancer early, without exposing patients to the risks of biopsy and surgery," Patz said. "This study is an important step in the right direction."
The researchers will next perform a larger study looking at the use of biomarkers prospectively in patients found to have lung lesions by CT scan. The ultimate goal is to develop a screening system by which patients could have the blood test before imaging and those found to be in a "high risk bin" would have a CT scan for further evaluation.
"We would determine whether the person is at low or high risk of having lung cancer based on these biomarkers," Patz said. "Patients at low risk might be followed with further blood tests or imaging studies while those at high risk might require immediate intervention."
Lung cancer is the leading killer of men and women in the United States, with nearly 175,000 people diagnosed each year, and about 160,000 patients dying from the disease yearly. More than 75 percent of lung cancer patients have already experienced significant disease spread by the time they are diagnosed, making the need for early detection techniques imperative.
Duke University Medical Center
Lung Cancer Current Events and Lung Cancer News RSSStudy of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer
Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results.
Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer
Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians.
Preventative brain radiation for lung cancer patients: Benefits and risks
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Study spotlights efficacy of questionnaire to identify patients at high risk for lung cancer
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer.
Intervals between lung cancer diagnosis and treatment displays a health care disparity
Research published in the November 2009 issue of the Journal of Thoracic Oncology has found that intervals between lung cancer suspicion, diagnosis and treatment may be attributed to health care system discrepancies.
Researchers use drug-radiation combo to eradicate lung cancer
Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.
Experts issue call to reconsider screening for breast cancer and prostate cancer
Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."
Detecting the undetectable in prostate cancer screening
A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
New data: Hospital imaging centers poised to pull back, hitting patients hardest in rural areas
Survivors and patients with cancers and heart disease, along with patient advocate organizations and physicians, today urged policymakers to enhance early diagnosis of deadly diseases by preserving access to advanced imaging, such as MRI and CT scans, in final health care reform legislation.
African American lung cancer patients may have different response to new cancer-fighting drugs
Clinical research out of University Hospitals Case Medical Center has found that African Americans with a common form of lung cancer have a lower frequency of drug-sensitizing genetic mutations, which may impact response to new cancer-fighting drugs.
More Lung Cancer Current Events and Lung Cancer News Articles
 |
How to Survive Lung Cancer - A Practical 12-Step Plan by Michael Lloyd (Author) Written by a lung cancer survivor who understands what it takes to beat the odds, this book offers unparalleled hope and direction for anyone facing this illness. It is filled with specific exercises and techniques to promote healing and reverse side effects by taking a pro-active approach in helping to restore your mind, body and spirit to an optimum state of health. Endorsed by a Lung Cancer Specialist and Associate Professor at Harvard Medical School, this book combines what the doctors tell you with critical information they don't tell you. Visit www.SurviveLungCancer.com for chapter summaries. |
 |
Lung Cancer: Myths, Facts, Choices--and Hope by Claudia I. Henschke (Author), Peggy McCarthy (Author), Sarah Wernick (Contributor) Winner of the 2003 American Society of Journalists and Authors' June Roth Memorial Award for Health and Medical Books. An authoritative book with new lifesaving strategies for those at risk and those already diagnosed. Lung cancer kills more women than breast cancer, more men than prostate cancer—because it's usually found too late. Claudia Henschke's groundbreaking research on early diagnosis, published in The Lancet, made headlines worldwide. Now, for the first time, she offers specific recommendations based on her latest findings: who needs to be checked, where to be tested, and what to expect. Dr. Henschke and coauthor Peggy McCarthy, a leading patient advocate, provide up-to-the-minute information on diagnosis, treatment, and survival, accompanied by inspiring words from... |
 |
Voices of Lung Cancer: The Healing Companion: Stories for Courage, Comfort and Strength (Voices Of series) by The Healing Project (Editor), S. Epatha Merkerson (Editor) Provided by the patients, their friends, families, and caregivers of those diagnaosed with lung cancer, these very personal stories offer inspired insight into the ways families and professionals care for both themselves and the patient, gain a deeper understanding of the relationships, and learn to come to terms with the end of life. Included are essays by medical experts about the science of lung cancer, current treatments, choosing the right doctors, and what the future holds for the next generation of patients. |
 |
Lung Cancer by Jack A. Roth (Author), James D. Cox (Author), Waun Ki Hong (Author) Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made. |
 |
Mom Lung Cancer Support Infant/Toddler T-Shirt by CafePress |
 |
Lung Cancer: Dana-Farber Cancer Institute Handbook (Dana-Farber Cancer Institute Handbooks) by Arthur T. Skarin MD FACP FCCP (Editor), Paul Lorigan MB FRCP (Editor) Written by highly eminent authors, Lung Cancer - a handbook in the Dana-Farber Cancer Institute series - is produced in full color and is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are also discussed in detail, particularly the management of metastatic lung disease in the context of new and emerging treatments. Comprehensive coverage - from risk and prevention, and screening and diagnosis, through to treatment options (surgery,... |
 |
Quick Facts on Lung Cancer by American Cancer Society (Author) Educate yourself about lung cancer What are your risk factors for lung cancer? Can you prevent it? How is lung cancer treated? What should you ask your doctor? QuickFACTS Lung Cancer is both a comprehensive and a quick read, with highlighted cover tabs for quick reference of specific topics. QuickFACTS Lung Cancer: Covers everything from risk factors to living well after cancer treatment Provides critical questions to ask your healthcare team Educates and empowers you right from the start Completely updated with the latest patient treatment guidelines Includes a lung cancer dictionary |
 |
Lung Cancer: Making Sense of Diagnosis, Treatment, and Options by Lorraine Johnston (Author) Lung cancer is the top cancer killer in the U.S. Yet it receives little attention from the media, and those with lung cancer suffer more blame and stigma than other cancer patients, even though 50 percent of them are former smokers or have never smoked. Lung cancer treatments and the daunting prognosis for some types and stages of lung cancer can significantly impact quality of life. In straightforward language, Lung Cancer: Making Sense of Diagnosis, Treatment & Options addresses its readers' medical, emotional, and support needs. The book includes stories from patients themselves, their families and their healthcare professionals. Author and patient advocate Lorraine Johnston emphasizes using knowledge to dispel fear. The content has been reviewed by top medical experts and physicians... |
 |
Lung Cancer by Cancer In Plain English Cancer touches almost everyone. The diagnosis of cancer leaves us with many difficult decisions to make. These decisions, especially in the early days of the diagnosis, are of crucial importance. Many times we find ourselves needing to make these important treatment decisions and cannot find cancer information that is easy to understand. These audio CDs will give you easily understood cancer information and the peace of mind that comes with a better understanding about this disease. |
 |
Mom Lung Cancer Support Kids Dark T-Shirt by CafePress |
| © 2009 BrightSurf.com |